Absci stock surges 24% on positive Phase 1 hair loss drug data
Investing.com Gold reports: Absci stock surges 24% on positive Phase 1 hair loss drug data. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Absci stock surges 24% on positive Phase 1 hair loss drug data. Full body text was unavailable at ingest time, so this brief is based on headline context.